Lithium - A continuing story in the treatment of bipolar disorder

Acta Psychiatrica Scandinavica, Supplement

Volumn 111, Issue 426, 2005, Pages 7-12

  Carney, S M ^a   Goodwin, G M ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Bipolar disorder; Evidence based medicine; Lithium; Mood stabilizer; Trials

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHLORPROMAZINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; TRANQUILIZER;

AKATHISIA; BIPOLAR DISORDER; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRY EYE; HUMAN; HYPOTHYROIDISM; MANIA; NAUSEA; POLYURIA; PSYCHOPHARMACOLOGY; RELAPSE; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; SOMNOLENCE; SUICIDE; TACHYCARDIA; THIRST; TINNITUS; TREATMENT OUTCOME; CONTROLLED CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

BIPOLAR DISORDER; HUMANS; LITHIUM; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SUICIDE; TRANQUILIZING AGENTS;

EID: 18044383552     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2005.00521.x     Document Type: Review

References (43)

1. COPPEN A. 50 years of lithium treatment of mood disorders. Bipolar Disord 1999;1:3-4.
2. JAMISON KR, AKISKAL HS. Medication compliance in patients with bipolar disorder. Psychiatr Clin North Am 1983;6:175-192.
3. PERLIS RH, SACHS GS, LAFER B et al. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry 2002;159:1155-1159.
4. MONCRIE J. Lithium: evidence reconsidered. Br J Psychiatry 1997;171:113-119.
5. GELENBERG AJ, KANE JM, KELLER MB et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989;321:1489-1493.
6. BURGESS S, GEDDES J, HAWTON K, TOWNSEND E, JAMISON K, GOODWIN G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev 2001; Issue 3.
7. GEDDES JR, BURGESS S, HAWTON K, JAMISON K, GOODWIN GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004;161:217-222.
8. POOLSUP N, LI WAN PA, DE OLIVEIRA IR. Systematic overview of lithium treatment in acute mania. J Clin Pharm Ther 2000;25:139-156.
9. CADE JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949;2:349-352.
10. GEDDES J. Bipolar disorder. Clin Evid 2004;11:1204-1223.
11. MACRITCHIE K, GEDDES JR, SCOTT J, HASLAM D, DE LIMA M, GOODWIN G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev 2003; Issue 1.
12. PRIEN RF, CAEY EM Jr, KLETT CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1972;26:146-153.
13. BERK M, ICHIM L, BROOK S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999;14:339-343.
14. SACHS GS, PRINTZ DJ, KAHN DA, CARPENTER D, DOCHERTY JP. The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med 2000; Special Report:1-104.
15. COOKSON J. Use of antipsychotic drugs and lithium in mania. Br J Psychiatry Suppl 2001;41:S148-S156.
16. GOODWIN GM. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003;17:149-173.
17. BAUER MS, MITCHNER L. What is a 'mood stabilizer'? An evidence-based response. Am J Psychiatry 2004;161:3-18.
18. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159:1-50.
19. BAUER MS, CALLAHAN AM, JAMPALA C et al. Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry 1999;60:9-21.
20. SUPPES T, SWANN AC, DENNEHY EB et al. Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. J Clin Psychiatry 2001;62:439-447.
21. BHAGWAGAR Z, GOODWIN GM. The role of lithium in the treatment of bipolar depression. Clin Neurosc Res 2004;2:222-227.
22. BOWDEN CL, CALABRESE JR, MCELROY SL et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000;57:481-489.
23. BOWDEN CL, CALABRESE JR, SACHS G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400.
24. BOWDEN CL, GHAEMI SN, GYULAI L et al. Lamotrigine delays mood episodes in recently depressed bipolar I patients, Annual Meeting New Research Program and Abstracts. Washington DC: American Psychiatric Association, 2002.
25. GEDDES JR, BURGESS S, HAWTON K, JAMISON K, GOODWIN GM. Correction. Am J Psychiatry 2004;161:1517.
26. GOODWIN GM. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 1994;164:149-152.
27. JOHNSON RE, MCFARLAND BH. Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry 1996;153:993-1000.
28. MACRITCHIE KA, GEDDES JR, SCOTT J, HASLAM DR, GOODWIN GM. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 2001; Issue 3.
29. DAVIS JM, JANICAK PG, HOGAN DM. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis. Acta Psychiatr Scand 1999;100:406-417.
30. HARTONG EG, MOLEMAN P, HOOGDUIN CA, BROEKMAN TG, NOLEN WA. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 2003;64:144-151.
31. CALABRESE JR, BOWDEN CL, SACHS G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013-1024.
32. INSKIP HM, HARRIS EC, BARRACLOUGH B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 1998;172:35-37.
33. HARRIS EC, BARRACLOUGH B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997;170:205-228.
34. JAMISON KR. Suicide and bipolar disorder. J Clin Psychiatry 2000;61(suppl. 9):47-51.
35. CIPRIANI A, WILDER H, HAWTON K, GEDDES JR. Lithium in the prevention of suicidal behaviour and all-cause mortality in patients with mood disorders: a systematic review of randomised trials. Am J Psychiatry, 2005 (In Press).
36. DUNNER DL. Correlates of suicidal behavior and lithium treatment in bipolar disorder. J Clin Psychiatry 2004;65(suppl. 10):5-10.
37. BALDESSARINI RJ, TONDO L, HENNEN J. Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium. Ann NY Acad Sci 2001;932:24-38.
38. GOODWIN FK, FIREMAN B, SIMON GE, HUNKELER EM, LEE J, REVICKI D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003;290:1467-1473.
39. WALKER AM. Confounding by indication. Epidemiology 1996;7:335-336.
40. KLEINDIENST N, GREIL W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000;42(suppl. 1):2-10.
41. SACHS GS, THASE ME, OTTO MW et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2003;53:1028-1042.
42. GEDDES J, GOODWIN G. Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials. Br J Psychiatry 2001;41(suppl.):S191-S194.
43. RENDELL JM, JUSZCZAK E, HAINSWORTH J et al. Developing the BALANCE trial - the role of the pilot study and start-up phase. Bipolar Disord 2004;6:26-31.